<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medvis</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская визуализация</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Visualization</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-0763</issn><issn pub-type="epub">2408-9516</issn><publisher><publisher-name>RDS-Media Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24835/1607-0763-2020-3-76-87</article-id><article-id custom-type="elpub" pub-id-type="custom">medvis-952</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ГРУДНАЯ КЛЕТКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>THORAX</subject></subj-group></article-categories><title-group><article-title>2D Speckle Tracking эхокардиография в прогнозировании диастолической дисфункции левого желудочка</article-title><trans-title-group xml:lang="en"><trans-title>2D Speckle Tracking echocardiography in the prognostication of left ventricle diastolic dysfunction</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5752-0988</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жерко</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zherko</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жерко Ольга Михайловна – канд. мед. наук, доцент, заведующая кафедрой ультразвуковой диагностики</p><p>Республика Беларусь, Минск, ул. П. Бровки, д. 3, к. 3</p></bio><bio xml:lang="en"><p>Olga M. Zherko – Cand. of Sci. (Med.), Associate Professor, Head of the Department of Ultrasound Diagnostics</p><p>3, building 3, P. Brovka str., Minsk, Republic of Belarus</p></bio><email xlink:type="simple">zherco@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9641-4846</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шкребнева</surname><given-names>Э. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Shkrebneva</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шкребнева Элина Ивановна – заведующая отделением функциональной диагностики</p><p>Республика Беларусь, Минск, ул. Семашко, д. 8</p></bio><bio xml:lang="en"><p>Elina I. Shkrebneva – Head of the functional diagnostics department</p><p>8, Semashko str., Minsk, Republic of Belarus</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Белорусская медицинская академия последипломного образования</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus, Department of Ultrasound Diagnostics</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Минский научно-практический центр хирургии, трансплантологии и гематологии</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology, Belarus, functional diagnostics department</institution><country>Belarus</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>09</day><month>10</month><year>2020</year></pub-date><volume>24</volume><issue>3</issue><fpage>76</fpage><lpage>87</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Жерко О.М., Шкребнева Э.И., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Жерко О.М., Шкребнева Э.И.</copyright-holder><copyright-holder xml:lang="en">Zherko O.M., Shkrebneva E.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medvis.rdsmedia.ru/jour/article/view/952">https://medvis.rdsmedia.ru/jour/article/view/952</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования: разработать комплексные критерии прогнозирования диастолической дисфункции (ДД) левого желудочка (ЛЖ) по данным 2D Speckle Tracking эхокардиографии (STE).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В 2019 г. на базе ГУ “Минский научно-практический центр хирургии, транс- плантологии и гематологии” выполнено клинико-инструментальное исследование 91 пациента в возрасте 64 (58–70) лет. Критерии включения: синусовый ритм, эссенциальная артериальная гипертензия, хроническая ишемическая болезнь сердца, перенесенный в прошлом инфаркт миокарда ЛЖ, после которого прошло не менее полугода, необходимого для стабилизации структурно-функциональных показателей ЛЖ, хроническая сердечная недостаточность, информированное согласие пациента. Критерии исключения: первичная митральная регургитация, митральный стеноз, пластика или протезирование митрального клапана, врожденные пороки сердца, острые и хронические заболевания почек, легких. Трансторакальная эхокардиография и STE выполнялись на ультразвуковом аппарате Vivid E9 (GE Healthcare, США).</p></sec><sec><title>Результаты</title><p>Результаты. Ведущими функциональными аномалиями, взаимосвязанными с ДД ЛЖ при сохраненной фракции выброса ЛЖ, являются снижение продольных диастолических, регионарных и глобальной систолических деформаций, механическая дисперсия и диссинергия миокарда ЛЖ. Установлена корреляционная зависимость между ДД ЛЖ II типа и индексом механической дисперсии (r = 0,69, p &lt; 0,001), дельтой времени до пиковой продольной деформации ЛЖ (r = 0,66, p &lt; 0,001), глобальным постсистолическим индексом ЛЖ (r = 0,58, p &lt; 0,001), GLSAVG (r = 0,63, р &lt; 0,001). Для ДД ЛЖ характерны значения ранней диастолической продольной деформации Е базально-латерального сегмента ЛЖ &gt; −6,75%, базально-септального сегмента ЛЖ &gt; −5,22%, отношения ранней и поздней диастолических продольных деформаций Е/А базально-латерального сегмента ≤0,91, базальносептального сегмента ≤0,69. При ДД ЛЖ I типа индекс механической дисперсии составляет &gt;49,34 мс, дельта времени до пиковой продольной деформации ЛЖ &gt;157 мс. Прогностическими для ДД II типа являются индекс механической дисперсии &gt;49,34 мс, дельта времени до пиковой продольной деформации &gt;136 мс, глобальный постсистолический индекс &gt;6,24%, индекс механической диссинергии &gt;4,60%, глобальное пиковое продольное смещение ЛЖ ≤9,88 мм, GLSAVG &gt; −18,5% (чувствительность 88,2%, специфичность 83,3%).</p></sec><sec><title>Выводы</title><p>Выводы. Применение в практическом здравоохранении разработанных прогностических показателей STE позволит повысить эффективность диагностики ДД ЛЖ.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>The aim of the study</title><p>The aim of the study: to develop prediction comprehensive criteria for the diastolic dysfunction (DD) of the left ventricle (LV) according to 2D Speckle Tracking echocardiography (STE).</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A clinical and instrumental study of 91 patients aged 64.0 was performed [58.0; 70.0] years in the Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology in 2019. Criteria for inclusion: sinus rhythm, essential arterial hypertension, chronic coronary artery disease, previous left myocardial infarction, after which at least six months have passed to stabilize the LV structural and functional parameters, chronic heart failure, patient informed consent. Exclusion criteria: primary mitral regurgitation, mitral stenosis, mitral valve repair or prosthetics, congenital heart defects, acute and chronic diseases of the kidneys, lungs. Transthoracic echocardiography and STE was performed on ultrasound machine Vivid E9 (GE Healthcare, USA).</p></sec><sec><title>Results</title><p>Results. The leading functional anomalies, interconnected in the development of LV DD, are decline of the LV longitudinal diastolic, regional and global systolic strain, LV mechanical dispersion and dyssynergy. Correlations between LV DD type II and the mechanical dispersion index (r = 0.69, p &lt; 0.001), delta of LV time to peak longitudinal deformation (r = 0.66, p &lt; 0.001), LV global post-systolic index (r = 0.58, p &lt; 0.001), GLSAVG (r = 0.63, p &lt; 0.001) were established. LV DD is characterized by early diastolic longitudinal strain E of the LV basal lateral segment &gt; −6.75%, LV basal septal segment &gt; −5.22%, early and late diastolic longitudinal strain ratio E/A of the LV basal lateral segment ≤0.91, basal-septal segment ≤0.69. LV DD type I is characterized by an LV mechanical dispersion index &gt;49.34 ms, LV delta time to peak longitudinal strain &gt;157 ms. Prognostic values for LV DD type II are LV mechanical dispersion index &gt;49.34 ms, delta time to peak longitudinal strain is &gt;136 ms, global post-systolic index &gt;6.24%, mechanical dyssynergy index &gt;4.60%, global LV peak longitudinal displacement ≤9.88 mm, GLSAVG &gt; −18.5% (sensitivity 88.2%, specificity 83.3%).</p></sec><sec><title>Conclusions</title><p>Conclusions. The use of the developed STE prediction value in practical public health will increase the efficiency of diagnosis of LV DD.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>2D Speckle Tracking эхокардиография</kwd><kwd>диастолическая дисфункция левого желудочка</kwd></kwd-group><kwd-group xml:lang="en"><kwd>2D Speckle Tracking echocardiography</kwd><kwd>diastolic dysfunction of the left ventricle</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Жерко О.М. Клиническая трансторакальная эхокардиография. Минск: Альфакнига, 2016. 832 с.</mixed-citation><mixed-citation xml:lang="en">Zherko О.М. Clinical transthoracic echocardiography. Minsk: Al'fakniga, 2016. 832 р. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Collier P., Phelan D., Klein A.A. Test in Context: Myocardial Strain Measured by Speckle-Tracking Echocardiography. J. Am. Coll. Cardiol. 2017; 69: 1043–1056. https://doi.org/10.1016/j.jacc.2016.12.012</mixed-citation><mixed-citation xml:lang="en">Collier P., Phelan D., Klein A.A. Test in Context: Myocardial Strain Measured by Speckle-Tracking Echocardiography. J. Am. Coll. Cardiol. 2017; 69: 1043–1056. https://doi.org/10.1016/j.jacc.2016.12.012</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Nagueh S.F., Smiseth O.A., Appleton C.P., Byrd B.F .3rd, Dokainish H., Edvardsen T., Flachskampf F.A., Gillebert T.C., Klein A.L., Lancellotti P., Marino P., Oh J.K., Popescu B.A., Waggoner A.D. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. JASE. 2016; 29: 277–314. https://doi.org/10.1016/j.echo.2016.01.011</mixed-citation><mixed-citation xml:lang="en">Nagueh S.F., Smiseth O.A., Appleton C.P., Byrd B.F .3rd, Dokainish H., Edvardsen T., Flachskampf F.A., Gillebert T.C., Klein A.L., Lancellotti P., Marino P., Oh J.K., Popescu B.A., Waggoner A.D. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. JASE. 2016; 29: 277–314. https://doi.org/10.1016/j.echo.2016.01.011</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuzoe H., Tanaka H., Matsumoto K., Toki H., Shimoura H., Ooka J., Sano H., Sawa T., Motoji Y., Mochizuki Y., Ryo K., Fukuzawa K., Yoshida A., Hirata K. Left ventricular dyssynergy and dispersion as determinant factors of fatal ventricular arrhythmias in patients with mildly reduced ejection fraction. Eur. Heart J. Cardiovasc. Imaging. 2016; 17: 334–342. https://doi.org/10.1093/ehjci/jev172</mixed-citation><mixed-citation xml:lang="en">Matsuzoe H., Tanaka H., Matsumoto K., Toki H., Shimoura H., Ooka J., Sano H., Sawa T., Motoji Y., Mochizuki Y., Ryo K., Fukuzawa K., Yoshida A., Hirata K. Left ventricular dyssynergy and dispersion as determinant factors of fatal ventricular arrhythmias in patients with mildly reduced ejection fraction. Eur. Heart J. Cardiovasc. Imaging. 2016; 17: 334–342. https://doi.org/10.1093/ehjci/jev172</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Otto C. The practice of clinical echocardiography. 5nd ed. Philadelphia, Pennsylvania: Elsevier, 2017. 965 р.</mixed-citation><mixed-citation xml:lang="en">Otto C. The practice of clinical echocardiography. 5nd ed. Philadelphia, Pennsylvania: Elsevier, 2017. 965 р.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Voigt J.U., Pedrizzetti G., Lysyansky P., Marwick T.H., Houle H., Baumann R., Pedri S., Ito Y., Abe Y., Metz S., Song J.H., Hamilton ., Sengupta P.P., Kolias T.J., d'Hooge J., Aurigemma G.P., Thomas J.D., Badano L.P. Definitions for a Common Standard for 2D Speckle Tracking Echocardiography. Consensus document of the EACVI/ASE/Industry Task Force to Standardize Deformation Imaging. Eur. Heart J. Cardiovasc. Imaging. 2015; 16: 1–11. https://doi.org/ 10.1093/ehjci/jeu184</mixed-citation><mixed-citation xml:lang="en">Voigt J.U., Pedrizzetti G., Lysyansky P., Marwick T.H., Houle H., Baumann R., Pedri S., Ito Y., Abe Y., Metz S., Song J.H., Hamilton ., Sengupta P.P., Kolias T.J., d'Hooge J., Aurigemma G.P., Thomas J.D., Badano L.P. Definitions for a Common Standard for 2D Speckle Tracking Echocardiography. Consensus document of the EACVI/ASE/Industry Task Force to Standardize Deformation Imaging. Eur. Heart J. Cardiovasc. Imaging. 2015; 16: 1–11. https://doi.org/ 10.1093/ehjci/jeu184</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Čelutkienė J., Plymen C.M., Flachskampf F.A., de Boer R.A., Grapsa J., Manka R., Anderson L., Garbi M., Barberis V., Filardi P.P., Gargiulo P., Zamorano J.L., Lainscak M., Seferovic P., Ruschitzka F., Rosano G.M.C., Nihoyannopoulos P. Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2018; 20: 1615–1633. https://doi.org/ 10.1002/ejhf.1330</mixed-citation><mixed-citation xml:lang="en">Čelutkienė J., Plymen C.M., Flachskampf F.A., de Boer R.A., Grapsa J., Manka R., Anderson L., Garbi M., Barberis V., Filardi P.P., Gargiulo P., Zamorano J.L., Lainscak M., Seferovic P., Ruschitzka F., Rosano G.M.C., Nihoyannopoulos P. Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2018; 20: 1615–1633. https://doi.org/ 10.1002/ejhf.1330</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Su M.Y., Lin L.Y., Tseng Y.H., Chang C.C., Wu C.K., Lin J.L., Tseng W.Y. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF. JACC Cardiovasc. Imaging. 2014; 7: 991–997. https://doi.org/ 10.1016/j.jcmg.2014.04.022</mixed-citation><mixed-citation xml:lang="en">Su M.Y., Lin L.Y., Tseng Y.H., Chang C.C., Wu C.K., Lin J.L., Tseng W.Y. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF. JACC Cardiovasc. Imaging. 2014; 7: 991–997. https://doi.org/ 10.1016/j.jcmg.2014.04.022</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">de Boer R.A., De Keulenaer G., Bauersachs J. et al. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. EJHF. 2019; 21: 272–285. https://doi.org/ 10.1002/ejhf.1406</mixed-citation><mixed-citation xml:lang="en">de Boer R.A., De Keulenaer G., Bauersachs J. et al. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. EJHF. 2019; 21: 272–285. https://doi.org/ 10.1002/ejhf.1406</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Жерко О.М. Давление наполнения левого желудочка как гемодинамический механизм прогрессии хронической сердечной недостаточности. Здравоохранение. 2019. 10: 5–9.</mixed-citation><mixed-citation xml:lang="en">Zherko O.M. Left ventricular filling pressure as a hemodynamic mechanism of the progression of chronic heart failure. Zdravookhraneniye = Healthcare. 2019; 10: 5–9. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Redfield M.M., Jacobsen S.J., Burnett J.C. Jr, Mahoney D.W., Bailey K.R., Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003; 289 (2): 194–202. https://doi.org/ 10.1001/jama.289.2.194</mixed-citation><mixed-citation xml:lang="en">Redfield M.M., Jacobsen S.J., Burnett J.C. Jr, Mahoney D.W., Bailey K.R., Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003; 289 (2): 194–202. https://doi.org/ 10.1001/jama.289.2.194</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
